BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2009
View Archived Issues
SJL-01 exhibits safety and potent anti-leishmania activity in preclinical evaluation
Read More
Rohto claims novel collagen production-promoting peptides for RA
Read More
Novel nAChR modulators in early development at NeuroSearch
Read More
Amira Pharmaceuticals describes CRTH2 antagonists for respiratory disorders
Read More
Novel compounds for the treatment of glaucoma claimed by Allergan
Read More
FDA clears Agriflu seasonal influenza vaccine
Read More
Lorus Therapeutics reports results of phase II LOR-2040 trial in AML
Read More
Spectrum completes enrollment in phase III trial of apaziquone in bladder cancer
Read More
Novel 2,3-dioxygenase inhibitor disclosed by Incyte for cancer immunotherapy
Read More
3,4-DAP obtains FDA orphan drug status for Lambert-Eaton myasthenic syndrome
Read More
S*BIO presents its novel, potent dual PI3K/mTOR inhibitor SB-2312
Read More
Proacta reports data on its novel hypoxia-activated pan-HER inhibitor
Read More
EMEA grants Clinuvel the status of small and medium enterprise
Read More
Chronic sildenafil improves clinical outcomes in heart failure patients
Read More
Lp-PLA2 levels did not predict CVD risk in atorvastatin-treated diabetic subjects
Read More
Bavarian Nordic to file for market approval for Imvamune smallpox vaccine in Canada
Read More
Novartis claims Toll-like receptor agonists for the treatment of asthma
Read More
CB1 receptor antagonists described by sanofi-aventis for the treatment of obesity
Read More
EMD Serono receives refuse to file letter from FDA on cladribine NDA
Read More
Cytokine completes phase I trial of CPSI-2364
Read More
Novavax completes enrollment in phase IIa seasonal influenza vaccine study
Read More
Angiox approved in E.U. for additional indication
Read More
FDA approves Cymbalta for maintenance treatment of GAD
Read More
Lundbeck initiates clinical phase II Lu-AE-58054 trials in Alzheimer's disease
Read More
Stemline Therapeutics expands oncology program directed at cancer stem cells
Read More
PPD completes acquisition of BioDuro
Read More
Tripep completes phase I trial of ChronVac-C hepatitis C virus DNA vaccine
Read More